Regeneron Pharmaceuticals, Inc. (BVMF:REGN34)
Brazil · Delayed Price · Currency is BRL 67.75
-0.15 (-0.22%)
At close: Feb 6, 2026
Regeneron Pharmaceuticals Market Cap
Regeneron Pharmaceuticals has a market cap or net worth of 420.74 billion as of February 6, 2026. Its market cap has decreased by -4.88% in one year.
Market Cap
420.74B
Enterprise Value
340.30B
Revenue
79.00B
Ranking
n/a
PE Ratio
16.96
Stock Price
67.75
Market Cap Chart
Since July 20, 1992, Regeneron Pharmaceuticals's market cap has increased from 177.17M to 420.74B, an increase of 237,382.24%. That is a compound annual growth rate of 26.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 420.74B | -3.54% |
| Dec 31, 2025 | 436.20B | -7.98% |
| Dec 31, 2024 | 474.01B | 4.59% |
| Dec 29, 2023 | 453.22B | 11.26% |
| Dec 30, 2022 | 407.37B | 10.73% |
| Dec 31, 2021 | 367.89B | 38.93% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rede D'Or São Luiz | 91.82B |
| Raia Drogasil | 46.29B |
| Hypera | 14.79B |
| Fleury | 9.18B |
| Odontoprev | 6.50B |
| Diagnósticos da América | 5.19B |
| Empreendimentos Pague Menos | 4.19B |
| Oncoclínicas do Brasil Serviços Médicos | 2.78B |